- Home
- DNLI vs HTH Comparison
DNLI vs HTH Comparison
Compare DNLI & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- HTH
- Stock Information
- Founded
- DNLI 2013
- HTH 1998
- Country
- DNLI United States
- HTH United States
- Employees
- DNLI N/A
- HTH N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- HTH Major Banks
- Sector
- DNLI Health Care
- HTH Finance
- Exchange
- DNLI Nasdaq
- HTH Nasdaq
- Market Cap
- DNLI 1.8B
- HTH 2.0B
- IPO Year
- DNLI 2017
- HTH 2004
- Fundamental
- Price
- DNLI $12.74
- HTH $28.63
- Analyst Decision
- DNLI Strong Buy
- HTH Hold
- Analyst Count
- DNLI 16
- HTH 2
- Target Price
- DNLI $37.57
- HTH $34.00
- AVG Volume (30 Days)
- DNLI 1.7M
- HTH 429.0K
- Earning Date
- DNLI 05-06-2025
- HTH 04-29-2025
- Dividend Yield
- DNLI N/A
- HTH 2.52%
- EPS Growth
- DNLI N/A
- HTH 3.22
- EPS
- DNLI N/A
- HTH 1.74
- Revenue
- DNLI N/A
- HTH $1,187,813,000.00
- Revenue This Year
- DNLI N/A
- HTH N/A
- Revenue Next Year
- DNLI $372.05
- HTH $3.18
- P/E Ratio
- DNLI N/A
- HTH $16.45
- Revenue Growth
- DNLI N/A
- HTH 0.88
- 52 Week Low
- DNLI $10.57
- HTH $26.67
- 52 Week High
- DNLI $33.33
- HTH $35.32
- Technical
- Relative Strength Index (RSI)
- DNLI 42.15
- HTH 40.56
- Support Level
- DNLI $12.37
- HTH $28.35
- Resistance Level
- DNLI $13.63
- HTH $28.99
- Average True Range (ATR)
- DNLI 1.24
- HTH 1.09
- MACD
- DNLI 0.23
- HTH -0.05
- Stochastic Oscillator
- DNLI 50.94
- HTH 38.55
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.